Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine contexts, while Dulaglutide is more of a metabolic peptide and Sermorelin is better described as a hormone peptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Dulaglutide leaning toward Metabolic regulation and Sermorelin leaning toward Anabolic growth and Lipolysis and fat loss. Dulaglutide has a more engineered peptide origin, while Sermorelin is closer to synthetic analog background. Dulaglutide takes the form of a peptide conjugate, whereas Sermorelin is closer to a linear peptide, while Sermorelin incorporates amidation features that are not part of Dulaglutide.